Oxytocin receptor (OXTR) expression patterns in the brain across development osf.io/j3b5d/
Here we identify OXTR gene expression patterns across the lifespan along with gene-gene co-expression patterns and potential health implications
[THREAD]
So, let's begin with some background.
As well as being an oxytocin researcher I'm also a meta-scientist, which means that a lot of my work on improving research methods is focused on improving oxytocin research (that's what got me into meta-science in the first place)
Earlier this year, we published a paper, led by @fuyu00, in which we proposed that three things are required to improving the precision of intranasal oxytocin research: Improved methods, reproducibility, and theory.
We used Tinbergen's "four questions" as a scaffold to develop this theory: how does oxytocin work; how does the role of oxytocin change during development; how does oxytocin enhance survival; and how did the oxytocin system evolve?
The theory was informed by lots of data on how the oxytocin system works and how it may enhance survival, but there's less data on how its role changes across development or how it evolved.
That's where this study comes in...
In a 2019 paper we reported oxytocin receptor expression patterns in the adult brain, which we linked to anticipatory, appetitive, and aversive cognitive states nature.com/articles/s4146…
So in our new study we used a similar approach to identify expression patterns across the brain (16 regions) AND across the lifespan (prenatal to 82 years old) via postmortem tissue from 57 human donors.
We found that OXTR expression begins to accelerate just before birth, with a peak level of expression occurring during early childhood (especially in males).
In particular, there was increased OXTR expression in the mediodorsal nucleus of the thalamus during early childhood
We also calculated the spatio-temporal correlation between OXTR and a geneset of interest from our previous work in adults, discovering a module of genes that co-express with OXTR both across the lifespan and across the brain (CD38, COMT, OPRK1, DRD2)
To assess the specificity of this result, we calculated the spatio-temporal relationship between OXTR and ALL available genes (n = 16659). The relationship with the dopamine receptor DRD2 was among the top 1.7% strongest relationships (b) and this was pretty stable over time (c)
To see if this pattern was a recent evolutionary feature, we performed the same analysis from rhesus macaque data across the lifespan, from the prenatal stage to early adulthood
Like our human analysis, we found an acceleration before birth, but no peak during early childhood.
We also did not find a strong relationship between OXTR and DRD2 gene expression, like we saw in the human data
Then, we went MUCH further back down the evolutionary tree using phylostratigraphy, which can identify which branch of the phylogenetic tree the original ancestor of a gene first appeared
As gene modules with high co-expression in the brain are related to molecular functions, we created a geneset containing the genes with the 100 strongest spatio-temporal correlations with OXTR
We found that most genes associated with OXTR expression are evolutionary ancient (the oldest phyostratum is cellular organisms)
We then calculated a transcriptional age index (TAI) for sixteen brain regions across five ontogenetic stages
to better understand the role of older vs. newer genes from this OXTR geneset module in brain development.
For all brain regions except the striatum (STR) and cerebellar cortex (CBC), the transcriptome of the OXTR top 100 geneset was older during the prenatal stage, compared to later stages
What also stood out here was that the mediodorsal nucleus of the thalamus (MD), which regulates decision making and behavioral flexibility, had a younger transcriptional age compared to all other regions from infancy to adulthood
To identify the source of this younger transcriptional age for MD, we calculated the *cumulative* contribution of genes from each phylostrata for MD, revealing that genes that first emerged during the 6th (eumetazoa) and 7th (bilateria) phylostrata has the largest contribution
What's interesting here is that complex nervous systems first emerged during the bilateria phylostrata and the differentiation of organs and tissues emerged during the eumetazoa phylostrata, in which eumetazoans used peptide signalling for cross-tissue communication
Next, we investigating the functional significance of spatio-temporal expression patterns of genes strongly
coupled with OXTR, finding enrichment in GWAS-derived genes for bone fracture in osteoporosis
Now bone isn't the first thing that comes to mind when it comes to oxytocin, but bone remodelling issues have been reported in autism, which has been associated with oxytocin system dysfunction pubmed.ncbi.nlm.nih.gov/17879151/
We also looked at the enrichment of this geneset in thirty tissue types across the body, discovering up-regulated differentially expressed genes in brain and lung tissue
So what are the health implications of the OXTR gene expression patterns across the lifespan?
To answer this, we extracted genesets from various psychiatric and psychological phenotypes
We found enrichment of the OXTR lifespan expression pattern in schizophrenia, IQ, general cognition, bone density, and BMI.
Finally, we confirmed that OXTR had high spatio-temporal differential stability from donor-to-donor (genes with differential stability scores in the top 50% of all genes are considered to be conserved) in humans and macaques
And here's your annual reminder that a "study" cannot be underpowered, but rather, a *design and test combination* can be underpowered for detecting hypothetical effect sizes of interest towardsdatascience.com/why-you-should…
If you want to determine the range of hypothetical effect sizes a that given field can reliably detect (and reject), here's a demo with #Rstats code sciencedirect.com/science/articl…
My guide to calculating study-level statistical power for meta-analyses using the 'metameta' #Rstats package and web app is out now in AMPPS 🔓 doi.org/10.1177/251524…
Here's how this tool can be used for your next meta-analysis OR for re-analysing published meta-analyses 🧵
There's been a lot of talk recently about the quality of studies that are included in meta-analyses—how useful is a meta-analysis if it's just made up of studies with low evidential value?
But determining the evidential value of studies can be hard. Common approaches for looking at study quality or risk of bias tend to be quite subjective. You're not likely to get the same conclusions from different authors. These tasks can also be quite time consuming.
“Nearly 100% of published studies… confirm the initial hypothesis. This is an amazing accomplishment given the complexity of the human mind and human behaviour. Somehow, as psychological scientists, we always find the expected result; we always win!” royalsocietypublishing.org/doi/10.1098/rs…
One thing I want to add: the psychological sciences need to broadly adopt practices that help us determine when we're wrong. The standard NHST p-value approach cannot be used to provide support for absence of an effect. This paper provides two solutions academic.oup.com/psychsocgeront…
Strong auxiliary assumptions are also required for falsifying hypotheses
Participants who ate soup from bowls that were refillable, unbeknownst to them, ate 73% more soup than those eating from normal bowls pubmed.ncbi.nlm.nih.gov/15761167/
I wonder if non-fungible tokens (NFTs) could be used as a kind of prediction market for research studies that will be considered ‘classics’ in the future?
This could maybe motive more robust work?
And you’re wondering what the heck an NFT is, here’s an explainer